Share the post "Shareholding Pattern: Shareholding Pattern Orchid Pharma Limited An Examination of Financial Performance for FY (Q4-Mar 2023-2024)"
Orchid Pharma Limited has unveiled its latest shareholding reports, covering the quarter and the first half of the fiscal year ending on (Q4-Mar 2023-2024).This comprehensive report offers a deep dive into the company’s shareholding landscape, including details on Promoters, promoter groups, Foreign investors, public investors, and government entities. Through meticulous comparative analysis, it tracks the evolution of shareholding percentages and quantities, highlighting any shifts in ownership dynamics. Investors gain invaluable insights into the company’s ownership structure and the evolving investment landscape.
| Shareholder Name | Previous Quater Quantity(In Crores) | Current Quater Quantity(In Crores) | Previous Quater Shares(in %) | Current Quater Shares(in %) | Quater to Quater Difference |
|---|---|---|---|---|---|
| Promoters | 3.54 | 3.54 | 69.84 | 69.84 | 0 |
| Public | 1.53 | 1.53 | 11.52 | 10.47 | -1.05 % |
| DII | 0.74 | 0.90 | 14.5 | 17.73 | +3.23 % |
| FII | 0.21 | 0.10 | 4.14 | 1.96 | -2.18 % |
| Government | 0.00 | 0.00 | 0 | 0 | 0 |
Promoters shareholding remained stable, at 69.84% in both December 2023 and March 2024. This indicates that the promoters’ control over the company did not change during this period. The percentage of shares held by the public decreased from 11.52% in December 2023 to 10.47% in March 2024.This reduction indicates that the public’s stake in the company diminished during this period.DIIs (Domestic Institutional Investors) shareholding increased from 14.5% in December 2023 to 17.73% in March 2024 , indicating that domestic institutions increased their stake in the company by 3.23% . FIIs (Foreign Institutional Investors) shareholding decreased from 4.14% in December 2023 to 1.96% in March 2024 ,indicating that foreign institutions reduced their investments by 1.5% in the company during the quarter. This suggests a pullback in their investment .During quater from December 2023 to March 2024, Goverenment ownership remained steady at 0%.This indicates that the government’s stake in the company remained consistent during this period.
Let’s delve deeper into the statistics of the investors, which could have contributed to the fluctuations in the shareholding pattern.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Resident Individuals holding nominal share capital up to Rs. 2 lakhs | 0.313 | 0.298 | 6.17 | 5.88 | -0.29 % |
| Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs | 0.082 | 0.079 | 1.62 | 1.56 | -0.06 % |
| Non Resident Indians (NRIs) | 0.014 | 0.019 | 0.28 | 0.37 | + 0.09 % |
| Bodies Corporate | 0.130 | 0.093 | 2.57 | 1.83 | -0.74 % |
| Any Other (specify) | 0.045 | 0.042 | 0.88 | 0.83 | -0.05 % |
| HUF | 0.018 | 0.015 | 0.35 | 0.29 | -0.06 % |
Observations indicate a sizeable -0.29 % variance in Resident Individuals holding nominal share capital up to Rs. 2 lakhs’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.06 % variance in Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Spearheading a savvy charge towards increased profitability, Non Resident Indians (NRIs) lifts the bar with a remarkable 0.09 % enhancement in net profit, revealing adroit resource allocation and sharpened commercial instincts.Observations indicate a sizeable -0.74 % variance in Bodies Corporate’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.05 % variance in Any Other (specify)’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.Observations indicate a sizeable -0.06 % variance in HUF’s fiscal performance between quarters, necessitating thorough investigation of salient aspects to enable future-proof strategies centered around lasting development.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Mutual Funds/ | 0.527 | 0.770 | 10.4 | 15.18 | + 4.78 % |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND | 0 | 0.072 | 0 | 1.43 | +1.43% |
| INVESCO INDIA CONTRA FUND & INVESCO INDIA SMALLCAP FUND ALONG WITH OTHER 4 NAMES | 0 | 0.201 | 0 | 3.97 | +3.97% |
| QUANT MUTUAL FUND-QUANT VALUE FUND, QUANT MULTI ASSET FUND, QUANT SMALL CAP FUND | 0 | 0.347 | 0 | 6.83 | +6.83% |
| Alternate Investment Funds | 0.078 | 0.076 | 1.54 | 1.5 | -0.04 % |
| CARNELIAN STRUCTURAL SHIFT FUND | 0 | 0.062 | 0 | 1.22 | +1.22% |
| Banks | 0.006 | 0.006 | 0.12 | 0.11 | -0.01 % |
| Insurance Companies | 0.124 | 0.048 | 2.45 | 0.94 | -1.51 % |
| UTI – HEALTHCARE FUND | 0.055 | 0 | 1.08 | 0 | -1.08% |
| Quant Mutual Fund Quant Value Fund | 0.067 | 0 | 1.32 | 0 | -1.32% |
| QUANT MUTUAL FUND QUANT MULTI ASSET FUND | 0.126 | 0 | 2.49 | 0 | -2.49% |
| QUANT MUTUAL FUND – QUANT SMALL CAP FUND | 0.153 | 0 | 3.03 | 0 | -3.03% |
| Nippon Life India Trustee Ltd – A/c Nippon Indian Pharma Fund | 0.086 | 0 | 1.69 | 0 | -1.69% |
| Carnelian Structural Shift fund | 0.062 | 0 | 1.22 | 0 | -1.22% |
| Max Life Insurance Company Limited A/c – ULIF00225/06/04LIFEBALANC104 – Balanced Fund | 0.124 | 0 | 2.44 | 0 | -2.44% |
The latest quarter saw a considerable enhancement in profitability for Mutual Funds/, reflecting an uptick of 4.78 % in their net earnings. Such an outcome implies the successful implementation of sound cost optimization techniques and increased income sources, ultimately highlighting the favorable effect of the investor on the corporation’s overall monetary welfare.Alternate Investment Funds decreased their stake from 1.5% in the previous quarter to 1.54% in the current quarter. It describes a decrease in stakes over consecutive quarters, specifically by -0.04 %.Banks decreased their stake from 0.11% in the previous quarter to 0.12% in the current quarter. It describes a decrease in stakes over consecutive quarters, specifically by -0.01 %.Insurance Companies decreased their stake from 0.94% in the previous quarter to 2.45% in the current quarter. It describes a decrease in stakes over consecutive quarters, specifically by -1.51 %.NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA PHARMA FUND had no shares in the previous quarter but now holds 1.43% of shares in the current quarter.INVESCO INDIA CONTRA FUND & INVESCO INDIA SMALLCAP FUND ALONG WITH OTHER 4 NAMES had no shares in the previous quarter but now holds 3.97% of shares in the current quarter.QUANT MUTUAL FUND-QUANT VALUE FUND, QUANT MULTI ASSET FUND, QUANT SMALL CAP FUND had no shares in the previous quarter but now holds 6.83% of shares in the current quarter.CARNELIAN STRUCTURAL SHIFT FUND had no shares in the previous quarter but now holds 1.22% of shares in the current quarter.UTI – HEALTHCARE FUND had 1.08% of shares in the previous quarter but exited in the current quarter.Quant Mutual Fund Quant Value Fund had 1.32% of shares in the previous quarter but exited in the current quarter.QUANT MUTUAL FUND QUANT MULTI ASSET FUND had 2.49% of shares in the previous quarter but exited in the current quarter.QUANT MUTUAL FUND – QUANT SMALL CAP FUND had 3.03% of shares in the previous quarter but exited in the current quarter.Nippon Life India Trustee Ltd – A/c Nippon Indian Pharma Fund had 1.69% of shares in the previous quarter but exited in the current quarter.Carnelian Structural Shift fund had 1.22% of shares in the previous quarter but exited in the current quarter.Max Life Insurance Company Limited A/c – ULIF00225/06/04LIFEBALANC104 – Balanced Fund had 2.44% of shares in the previous quarter but exited in the current quarter.
| Shareholder Name | Previous Quarter Quantity (In Crores) | Current Quarter Quantity (In Crores) | Previous Quater Shares (in %) | Current Quater Shares (in %) | Quater-to-Quater Difference (%) |
|---|---|---|---|---|---|
| Foreign Portfolio Investors Category I | 0.208 | 0.096 | 4.11 | 1.9 | -2.21 % |
| Foreign Portfolio Investors Category II | 0.002 | 0.003 | 0.03 | 0.06 | + 0.03 % |
| Massachusetts Institute of Technology | 0.148 | 0 | 2.91 | 0 | -2.91% |
Profitability dwindled by -2.21 % for Foreign Portfolio Investors Category I in comparison to the preceding quarter. To secure a foundation for prospective sustainable progress, investigating the factors prompting this decline is vital.During this past quarter, there was a noteworthy upswing in profitability for Foreign Portfolio Investors Category II, which experienced a significant increase of 0.03 % in net profit.Massachusetts Institute of Technology had 2.91% of shares in the previous quarter but exited in the current quarter.
[my_shortcode1 values=”Orchid Pharma Limited “]
